Home | News | Find a Doctor | Ask a Question | Free

Viviscal

Off another forum and published in Pubmed.

Lassus A, Eskelinen E.

Department of Dermatological Research, ARS-Medicina, Helsinki, Finland.

A controlled, randomized, double-blind, parallel-group study compared the effects of ViviScal (a new food supplement incorporating special marine extracts and a silica compound) with those of a fish extract in the treatment of young males with hereditary androgenic alopecia. The pretreatment histological diagnosis was alopecia with a mild to moderate perifollicular inflammation zone. The study consisted of 20 subjects who received two tablets of ViviScal once daily and 20 who received two tablets of fish extract once daily for 6 months. The mean patient age and mean duration and severity of baldness compared well between the two groups. Most patients had been treated with long-term topical 2% minoxidil for 1 year or more prior to the study. At baseline and after 6 months’ treatment, a biopsy was taken for histological examination. A non-vellus hair count was performed at baseline and after 2, 4 and 6 months. In the fish extract treatment group three patients withdrew from the study before the fourth month due to lack of therapeutic effect. After 6 months’ treatment, patients receiving ViviScal showed a mean increase in non-vellus hair of 38% compared with a 2% increase in the fish extract treatment group (P < 0.0001). In the ViviScal group, 19 (95%) subjects showed both clinical and histological cure, whereas none treated with fish extract showed any clinical or histological difference after 6 months’ treatment (P < 0.0001). In both groups, a minimal decrease in the erythemal index was observed. In conclusion, ViviScal appears to be the first highly active treatment for androgenic alopecia in young males."

» Off another forum and published in Pubmed.
»
» Lassus A, Eskelinen E.
»
» Department of Dermatological Research, ARS-Medicina, Helsinki, Finland.
»
» A controlled, randomized, double-blind, parallel-group study compared the
» effects of ViviScal (a new food supplement incorporating special marine
» extracts and a silica compound) with those of a fish extract in the
» treatment of young males with hereditary androgenic alopecia. The
» pretreatment histological diagnosis was alopecia with a mild to moderate
» perifollicular inflammation zone. The study consisted of 20 subjects who
» received two tablets of ViviScal once daily and 20 who received two
» tablets of fish extract once daily for 6 months. The mean patient age and
» mean duration and severity of baldness compared well between the two
» groups. Most patients had been treated with long-term topical 2% minoxidil
» for 1 year or more prior to the study. At baseline and after 6 months’
» treatment, a biopsy was taken for histological examination. A non-vellus
» hair count was performed at baseline and after 2, 4 and 6 months. In the
» fish extract treatment group three patients withdrew from the study before
» the fourth month due to lack of therapeutic effect. After 6 months’
» treatment, patients receiving ViviScal showed a mean increase in
» non-vellus hair of 38% compared with a 2% increase in the fish extract
» treatment group (P < 0.0001). In the ViviScal group, 19 (95%) subjects
» showed both clinical and histological cure, whereas none treated with fish
» extract showed any clinical or histological difference after 6 months’
» treatment (P < 0.0001). In both groups, a minimal decrease in the
» erythemal index was observed. In conclusion, ViviScal appears to be the
» first highly active treatment for androgenic alopecia in young males."

thats a bunch of crap
38 percent increase in non velous hair, ya right,
if that was true this would be all over the news

» » Off another forum and published in Pubmed.
» »
» » Lassus A, Eskelinen E.
» »
» » Department of Dermatological Research, ARS-Medicina, Helsinki, Finland.
» »
» » A controlled, randomized, double-blind, parallel-group study compared
» the
» » effects of ViviScal (a new food supplement incorporating special marine
» » extracts and a silica compound) with those of a fish extract in the
» » treatment of young males with hereditary androgenic alopecia. The
» » pretreatment histological diagnosis was alopecia with a mild to
» moderate
» » perifollicular inflammation zone. The study consisted of 20 subjects
» who
» » received two tablets of ViviScal once daily and 20 who received two
» » tablets of fish extract once daily for 6 months. The mean patient age
» and
» » mean duration and severity of baldness compared well between the two
» » groups. Most patients had been treated with long-term topical 2%
» minoxidil
» » for 1 year or more prior to the study. At baseline and after 6 months’
» » treatment, a biopsy was taken for histological examination. A
» non-vellus
» » hair count was performed at baseline and after 2, 4 and 6 months. In
» the
» » fish extract treatment group three patients withdrew from the study
» before
» » the fourth month due to lack of therapeutic effect. After 6 months’
» » treatment, patients receiving ViviScal showed a mean increase in
» » non-vellus hair of 38% compared with a 2% increase in the fish extract
» » treatment group (P < 0.0001). In the ViviScal group, 19 (95%) subjects
» » showed both clinical and histological cure, whereas none treated with
» fish
» » extract showed any clinical or histological difference after 6 months’
» » treatment (P < 0.0001). In both groups, a minimal decrease in the
» » erythemal index was observed. In conclusion, ViviScal appears to be the
» » first highly active treatment for androgenic alopecia in young males."
»
» thats a bunch of crap
» 38 percent increase in non velous hair, ya right,
» if that was true this would be all over the news

Logic tells me if these figures added up - the makers would have at least have some examples of people who had success.

If they are saying it slows male hairloss then thats different - however I doubt that very much either.

Regards
Pete

Home | News | Find a Doctor | Ask a Question | Terms of Use & Privacy

This is an advertising site for paid advertisers to showcase successful hair restoration results only. It is not the mandate of this site to engage in the discussion of failed, unsuccessful procedures, lawsuits, litigations, refunds or complaint cases. Surgical hair restoration procedures carry risks. Please do thorough research, consult your own physician and investigate a doctor's background carefully before making a decision. By proceeding to use our site, you agree to abide by our Terms of Use & Privacy Policy at http://hairsite.com/terms-of-use/ where you can also find a list of HairSite's sponsoring physicians.